MSN: Japan's answer to Ozempic: The metabo law that fights obesity like a pro
Japan's answer to Ozempic: The metabo law that fights obesity like a pro
A multi-pronged approach combining early detection, lifestyle changes and newly approved anti-obesity drugs could help curtail rising obesity rates in Japan, and ease the burden on the healthcare ...
TOKYO, Jan 13 (Reuters) - Japanese drugmaker Taisho Pharmaceutical Co <4535.T> said on Tuesday it has won rights to develop and market GlaxoSmithKline PLC's anti-obesity drug orlistat in Japan. Taisho ...
Nasdaq: Rhythm Pharmaceuticals Receives Orphan Drug Designation in Japan for Setmelanotide in Acquired Hypothalamic Obesity Treatment
Rhythm Pharmaceuticals Receives Orphan Drug Designation in Japan for Setmelanotide in Acquired Hypothalamic Obesity Treatment
Yahoo Finance: Novo Nordisk Targets Japan Self-Pay Market as Only 14,000 Access Obesity Drugs
This article first appeared on GuruFocus. Novo Nordisk (NYSE:NVO) is testing a new route to unlock obesity drug demand in Japan, where strict reimbursement rules have slowed uptake despite rising ...
Novo Nordisk Targets Japan Self-Pay Market as Only 14,000 Access Obesity Drugs
Yahoo News Canada: How Japan solved its obesity crisis – and what the UK can learn from it
Add Yahoo as a preferred source to see more of our stories on Google. Weighty issue: Japanese 'metabo' law, introduced in 2008, requires every citizen between 40 and 74 to meet required waistline ...
How Japan solved its obesity crisis – and what the UK can learn from it
NDTV: How Japan Got Lowest Obesity Rate In The World, And What India Can Learn From Them
Japan's biggest advantage is not discipline but design. Japan has one of the lowest obesity rates in the developed world. India, once stereotyped as undernourished, is now battling rising waistlines ...